On June 4, the Department of Consumer Protection updated the proposed opioid warning label regulation upon some corrections from the Legislative Commissioner’s Office.
The Department of Consumer Protection has also given notice that it proposes to adopt a regulation concerning Emergency and Hormonal Contraceptives. Public comment period is 30 days from June 4.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
The Commission of Pharmacy held its regular monthly meeting on January 31. Several licenses and disciplinary actions were considered; no policy decisions were on the agenda.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
The Department of Consumer Protection urges pharmacists to continue to offer to prescribe naloxone for patients, when appropriate. This includes when filling prescriptions for:
As some insurance providers, including Medicaid, may continue to cover Narcan and ReVive, pharmacists should continue to submit claims when dispensing naloxone prescribed by a pharmacist or other authorized prescriber. Patients whose insurance providers do not cover these medications should contact their insurance provider for more information. Additional information can be found on the Drug Control Division website.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
During this year’s legislation session, Connecticut Public Act 23-19 was passed, and pharmacists are now allowed to vaccinate children ages 12 years and up. Regulations are expected to be adopted by the Department of Consumer Protection, in consultation with the Commissioner of Public Health and the Commission of Pharmacy. While regulations and legal questions are worked through, the Department of Public Health (DPH) Immunization Program would like to assist you with enrollment in the Connecticut (Pediatric) Vaccine Program (CVP). Per CGS Sec. 19a-7f, all vaccines administered to children in Connecticut available through the CVP must be procured through the Immunization Program.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Gov. Ned Lamont (D) signed legislation (SB 1102) that allows pharmacists to order and administer COVID, flu and HIV (Human Immunodeficiency Virus) tests, pharmacists to prescribe and distribute HIV-related prophylaxis and pharmacists and technicians to administer vaccines. Governor Lamont signed another bill (HB 6768) that allows pharmacists to prescribe emergency and hormonal contraceptives.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
SB 1102, legislation that would allow pharmacists to administer additional vaccines, tests and drugs and pharmacies to operate mobile pharmacies, was reported out favorably by the General Laws Committee on March 9.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Earlier this month the finalized Connecticut State Budget, HB5506, included approved changes in the Collaborative Drug Therapy Management agreements between pharmacists and any prescribing practitioner and caregiving institutions to expand pharmacists’ authority to manage patient populations.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
The Connecticut Department of Consumer Protection adopted regulations under RCSA 20-576 to establish standards for shared pharmacy services, which are systems in which two or more licensed pharmacies process or dispense a prescription.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
NACDS urged the Connecticut Department of Energy and Environmental Protection (DEEP) to adopt the federal Pharmaceutical Hazardous Waste Rule (the Rule) as part of its next regulatory update for rules needed to implement the Resource Conservation and Recovery Act (RCRA). The adoption of the Federal Rule allows retailers to operate within a sector‐specific set of requirements which creates a level playing field.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.